Warning: The NCBI web site requires JavaScript to function. more...
Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy.
Mogtomo ML, Malieugoue LC, Djiepgang C, Wankam M, Moune A, Ngane AN.
Infect Agent Cancer. 2009 Jun 3;4:9.
Related citations
Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.
J Natl Cancer Inst. 2004 Jul 21;96(14):1070-6.
Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.
J Natl Cancer Inst. 2006 Jan 18;98(2):100-9.
Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women.
La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Touré-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G.
Int J Cancer. 1998 May 18;76(4):480-6.
Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
Sirera G, Videla S, López-Blázquez R, Llatjos M, Tarrats A, Castellà E, Grane N, Tural C, Rey-Joly C, Clotet B.
J Antimicrob Chemother. 2008 Jan;61(1):191-4. Epub 2007 Oct 31.
Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy.
Palefsky JM.
Curr Opin Oncol. 2003 Sep;15(5):382-8. Review.
Human papillomavirus types among women infected with HIV: a meta-analysis.
Clifford GM, Gonçalves MA, Franceschi S; HPV and HIV Study Group.
AIDS. 2006 Nov 28;20(18):2337-44.
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.
Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A.
Obstet Gynecol. 2009 Jan;113(1):26-31.
Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
Lehtovirta P, Paavonen J, Heikinheimo O.
Int J STD AIDS. 2008 Jan;19(1):37-41.
Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.
Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.
Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.
Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.
Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L.
Obstet Gynecol. 2008 Jun;111(6):1380-7.
Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group.
Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, Burns D, Greenblatt RM, Muderspach LI, Miotti P.
J Acquir Immune Defic Syndr. 1999 May 1;21(1):33-41.
Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.
Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C.
J Infect Dis. 2001 Sep 1;184(5):547-51. Epub 2001 Aug 9.
Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection.
Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M.
J Med Virol. 2008 May;80(5):847-55.
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
Uberti-Foppa C, Origoni M, Maillard M, Ferrari D, Ciuffreda D, Mastrorilli E, Lazzarin A, Lillo F.
J Med Virol. 1998 Oct;56(2):133-7.
The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.
Minkoff H, Ahdieh L, Massad LS, Anastos K, Watts DH, Melnick S, Muderspach L, Burk R, Palefsky J.
AIDS. 2001 Nov 9;15(16):2157-64.
Risk factors for cervical neoplasia in Denmark.
Kjaer SK.
APMIS Suppl. 1998;80:1-41.
Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
Heard I, Schmitz V, Costagliola D, Orth G, Kazatchkine MD.
AIDS. 1998 Aug 20;12(12):1459-64.
Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I, Potard V, Costagliola D.
Antivir Ther. 2006;11(8):1091-6.
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.
Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH.
Gynecol Oncol. 2006 Dec;103(3):1017-22. Epub 2006 Jul 27.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on